Press Releases

Date Title and Summary Additional Formats
Toggle Summary Novartis Partners with SHYFT to Support its Digital Transformation
Agreement accelerates Novartis’ ability to use data and digital to transform commercial models, ensuring more meaningful interactions with healthcare providers NEW YORK & WALTHAM, Mass. --(BUSINESS WIRE)--Jul. 24, 2018-- SHYFT Analytics , a Medidata Solutions (NASDAQ:MDSO) company, announced today
Toggle Summary Tetraphase Pharmaceuticals Selects SHYFT to Support Data and Analytics for Commercial Launch Readiness
Cloud-based data analytics platform will reduce the complexity of launching an antibiotic for complicated intra-abdominal infections, subject to approval by regulatory authorities
Toggle Summary Medidata NEXT Seoul and Shanghai Events Host Industry Thought Leaders at the Forefront of the Digital Transformation in Life Sciences
China Drug Administration and Celltrion Lead Keynote Sessions SHANGHAI --(BUSINESS WIRE)--Jul. 11, 2018-- This week, the Asia Pacific segment of Medidata’s (NASDAQ:MDSO) global NEXT series continues with customer events in Seoul and Shanghai . Sessions will explore trends in virtual trials, mobile
Toggle Summary Medidata Schedules Second Quarter Earnings Conference Call for July 24, 2018
NEW YORK --(BUSINESS WIRE)--Jul. 10, 2018-- Medidata (NASDAQ:MDSO), today announced that it will release its second quarter 2018 financial results before the open of the market on Tuesday, July 24, 2018 . The Company will also hold a conference call at 8:00 a.m.
Toggle Summary Medidata Appoints New China GM and Doubles Size of Talent in Region
Accelerating Innovation and Adoption for Industry Leading eClinical Platform SHANGHAI --(BUSINESS WIRE)--Jun. 28, 2018-- With China based customers doubling in 2017, Medidata (NASDAQ: MDSO) announced the appointment of Jim (Hui) Xu as general manager in the market, and plans to double the size of
Toggle Summary Clinical Research Can Now Be Truly Patient-Centric By Quantifying Patient Burden with Medidata
Patient Burden Index uses data-driven approach to provide objective insight when creating trial protocols to improve study retention and recruitment NEW YORK --(BUSINESS WIRE)--Jun. 25, 2018-- To make clinical research truly patient-centric, Medidata (NASDAQ: MDSO) announced the launch of the
Toggle Summary Medidata Defines the Future of Life Sciences with Acquisition of SHYFT Analytics
Leading the digital transformation of life sciences with artificial intelligence and advanced analytics NEW YORK --(BUSINESS WIRE)--Jun. 12, 2018-- Medidata (NASDAQ:MDSO) today announced that it has entered into a definitive agreement to acquire SHYFT Analytics , bringing the leading platform for
Toggle Summary Major Cancer Center Further Advances Oncology Research by Integrating Genomic Data Into Medidata's eClinical Platform
Pancreatic Cancer Research Exemplifies Increasing Use of Genomic Data for Precision Medicine NEW YORK --(BUSINESS WIRE)--May 23, 2018-- Medidata (NASDAQ: MDSO) announced that Memorial Sloan Kettering Cancer Center (MSK) is using Rave Omics with Biomarker Discovery for patients with pancreatic
Toggle Summary Medidata to Showcase Rave Omics with Biomarker Discovery in Oncology Research at Industry Expert Theater Presentation
Integration of Genomic and Clinical Trial Data Enables Biomarker Hypothesis Generation by Clinical Development NEW YORK --(BUSINESS WIRE)--May 21, 2018-- For the second consecutive year, Medidata (NASDAQ:MDSO) will be presenting its pioneering analytics innovation during the 2018 ASCO Annual
Toggle Summary PhaseBio Pharma Becomes Medidata’s 1,000th Customer, Making Company First in Industry to Achieve This Milestone
Innovative Biotech Company Adopts Medidata Rave EDC, Benefiting From a Unified Platform for All Phases of the Study NEW YORK --(BUSINESS WIRE)--May 17, 2018-- Biotech company, PhaseBio Pharmaceuticals , has become Medidata’s (NASDAQ:MDSO) 1,000th customer.

Investor Contact

Betsy Frank
+1 917 522 4620